Characteristic of the complete chloroplast genome of Symphoricarpos sinensis, an important ornamental plant endemic to China

由 Zhang, Yi, Zhang, Qing Yuan, Ran, Hang, Cao, Yanan
發表在 Mitochondrial DNA B Resour (2020)

Neoadjuvant Chemoradiotherapy vesus Chemotherapy alone Followed by Surgery for Resectable Stage III Non-Small-Cell Lung Cancer: a Meta-Analysis

由 Guo, Shan xian, Jian, Yan, Chen, Ying lan, Cai, Yun, Zhang, Qing yuan, Tou, Fang fang
發表在 Sci Rep (2016)

Estrogen receptor α mediates the effects of notoginsenoside R1 on endotoxin-induced inflammatory and apoptotic responses in H9c2 cardiomyocytes

由 ZHONG, LEI, ZHOU, XING-LU, LIU, YAN-SONG, WANG, YI-MIN, MA, FEI, GUO, BAO-LIANG, YAN, ZHAO-QI, ZHANG, QING-YUAN
發表在 Mol Med Rep (2015)

Managing Pain in Patients With Cancer: The Chinese Good Pain Management Experience

由 Yu, Shi-Ying, Wang, Jie-Jun, Huang, Yu-guang, Hu, Bing, Wang, Kun, Li, Ping Ping, Wu, Yi-Long, Zhang, He-Long, Zhang, Li, Zhang, Qing-Yuan, Qin, Shu-Kui
發表在 J Glob Oncol (2016)

Molecular Subtyping of Triple‐Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance

由 Zhao, Shen, Ma, Ding, Xiao, Yi, Li, Xiao‐Mei, Ma, Jian‐Li, Zhang, Han, Xu, Xiao‐Li, Lv, Hong, Jiang, Wen‐Hua, Yang, Wen‐Tao, Jiang, Yi‐Zhou, Zhang, Qing‐Yuan, Shao, Zhi‐Ming
發表在 Oncologist (2020)

A Polymorphism at the 3′-UTR Region of the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor, Anastrozole, in Metastatic Breast Carcinoma

由 Liu, Lei, Bai, Yu-Xian, Zhou, Jian-Hua, Sun, Xiu-Wei, Sui, Hong, Zhang, Wen-Jie, Yuan, Heng-Heng, Xie, Rui, Wei, Xiao-Li, Zhang, Ting-Ting, Huang, Peng, Li, Yan-Jing, Wang, Jing-Xuan, Zhao, Shu, Zhang, Qing-Yuan
出版 2013

Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)

由 Wang, Feng-Hua, Wei, Xiao-Li, Feng, Jifeng, Li, Qi, Xu, Nong, Hu, Xi-Chun, Liao, Wangjun, Jiang, Yi, Lin, Xiao-Yan, Zhang, Qing-yuan, Yuan, Xiang-Lin, Huang, Hai-Xin, Chen, Ye, Dai, Guang-Hai, Shi, Jian-Hua, Shen, Lin, Yang, Shu-Jun, Shu, Yong-Qian, Liu, Yun-Peng, Wang, Weifeng, Wu, Hai, Feng, Hui, Yao, Sheng, Xu, Rui-Hua
發表在 J Clin Oncol (2021)

MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study

由 Zhang, Qing Yuan, Sun, Tao, Yin, Yong Mei, Li, Hui Ping, Yan, Min, Tong, Zhong Sheng, Oppermann, Christina P., Liu, Yun Peng, Costa, Romulo, Li, Man, Cheng, Ying, Ouyang, Qu Chang, Chen, Xi, Liao, Ning, Wu, Xin Hong, Wang, Xiao Jia, Feng, Ji Feng, Hegg, Roberto, Kanakasetty, G.B., Coccia-Portugal, Maria A., Han, Ru Bing, Lu, Yi, Chi, Hai Dong, Jiang, Ze Fei, Hu, Xi Chun
發表在 Ther Adv Med Oncol (2020)

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

由 Johnston, Stephen R. D., Harbeck, Nadia, Hegg, Roberto, Toi, Masakazu, Martin, Miguel, Shao, Zhi Min, Zhang, Qing Yuan, Martinez Rodriguez, Jorge Luis, Campone, Mario, Hamilton, Erika, Sohn, Joohyuk, Guarneri, Valentina, Okada, Morihito, Boyle, Frances, Neven, Patrick, Cortés, Javier, Huober, Jens, Wardley, Andrew, Tolaney, Sara M., Cicin, Irfan, Smith, Ian C., Frenzel, Martin, Headley, Desirée, Wei, Ran, San Antonio, Belen, Hulstijn, Maarten, Cox, Joanne, O’Shaughnessy, Joyce, Rastogi, Priya
發表在 J Clin Oncol (2020)